Med Sci (Paris)
Volume 34, Number 10, Octobre 2018
Nos jeunes pousses ont du talent !
Page(s) 872 - 875
Section Partenariat médecine/sciences - Écoles doctorales - Masters
Published online 19 November 2018
  1. Turner NC, Huang Bartlett C, Cristofanilli M. Palbociclib in hormone-receptor-positive advanced breast cancer. N Engl J Med 2015 ; 373 : 209–219. [Google Scholar]
  2. Ledford H. Cocktails for cancer with a measure of immunotherapy. Nature 2016 ; 532 : 162–164. [CrossRef] [PubMed] [Google Scholar]
  3. Goel S, DeCristo MJ, Watt AC, et al. CDK4/6 inhibition triggers anti-tumour immunity. Nature 2018 ; 548 : 471–475. [Google Scholar]
  4. Deng J, , Jenkins Wang ES, et al. CDK4/6 inhibition augments anti-tumor immunity by enhancing T cell activation. Cancer Discovery 2018 ; 8 : 216–233. [CrossRef] [PubMed] [Google Scholar]
  5. Zhang J, Bu X, Wang H, et al. Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance. Nature 2018 ; 553 : 91–95. [CrossRef] [PubMed] [Google Scholar]
  6. Herbst RS, Soria JC, Kowanetz M, et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 2014 ; 515 : 563–567. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.